Yi Xiong

4.1k total citations · 2 hit papers
79 papers, 2.5k citations indexed

About

Yi Xiong is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yi Xiong has authored 79 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 27 papers in Molecular Biology and 22 papers in Oncology. Recurrent topics in Yi Xiong's work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (11 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Yi Xiong is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (11 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Yi Xiong collaborates with scholars based in China, United States and Hong Kong. Yi Xiong's co-authors include Berl R. Oakley, Tania Nayak, C. Elizabeth Oakley, Edyta Szewczyk, Stephen A. Osmani, Xuejun Li, Dongqiang Zeng, Li Sun, Yulin Liao and Zilan Ye and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Bioinformatics.

In The Last Decade

Yi Xiong

74 papers receiving 2.5k citations

Hit Papers

IOBR: Multi-Omics Immuno-... 2006 2026 2012 2019 2021 2006 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures
    2021 740 citations Yi Xiong, Xuejun Li et al. profile →
  2. Fusion PCR and gene targeting in Aspergillus nidulans
    2006 652 citations Yi Xiong et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Xiong China 20 1.5k 653 553 448 398 79 2.5k
Hisafumi Yamada‐Okabe Japan 36 2.2k 1.5× 327 0.5× 583 1.1× 578 1.3× 452 1.1× 78 3.7k
Xiaoxing Wang China 26 1.5k 1.0× 382 0.6× 565 1.0× 368 0.8× 157 0.4× 109 3.0k
Hongtao Liu China 32 2.0k 1.3× 287 0.4× 720 1.3× 1.1k 2.6× 136 0.3× 96 3.5k
Jae Yun Lim South Korea 24 1.0k 0.7× 405 0.6× 441 0.8× 364 0.8× 382 1.0× 62 1.9k
Lin Tang China 26 1.4k 0.9× 252 0.4× 337 0.6× 679 1.5× 150 0.4× 142 2.4k
Xueyi Dong China 35 2.7k 1.8× 318 0.5× 829 1.5× 1.3k 2.9× 178 0.4× 79 3.7k
Sang Seok Koh South Korea 29 2.8k 1.9× 127 0.2× 516 0.9× 350 0.8× 272 0.7× 63 3.5k
Jean‐Philippe Theurillat Switzerland 19 1.5k 1.0× 279 0.4× 588 1.1× 396 0.9× 62 0.2× 30 2.8k

Countries citing papers authored by Yi Xiong

Since Specialization
Citations

This map shows the geographic impact of Yi Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Xiong more than expected).

Fields of papers citing papers by Yi Xiong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Xiong. The network helps show where Yi Xiong may publish in the future.

Co-authorship network of co-authors of Yi Xiong

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Xiong. A scholar is included among the top collaborators of Yi Xiong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Xiong. Yi Xiong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhichun, et al.. (2025). Optimal ship fleet size in an inland river corridor with seasonal change in waterway depth. Transport Policy. 166. 108–123.
2.
Xiong, Yi, Miaomiao Yang, Nan Du, et al.. (2025). Effect of gradient nanostructures induced by supersonic fine particle bombardment on microstructure and properties of Ni-W-Co-Ta medium-heavy alloy. Transactions of Nonferrous Metals Society of China. 35(6). 1875–1889.
3.
Xiong, Yi, et al.. (2024). Cryogenic rolling impacts on microstructures and properties of a novel Ni–W–Co–Ta medium-heavy alloy. Transactions of Nonferrous Metals Society of China. 34(4). 1214–1225. 2 indexed citations
4.
Wang, Shixiang, Yi Xiong, Haitao Wang, et al.. (2024). TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 12(1). e008040–e008040. 7 indexed citations
5.
6.
7.
Chen, Minjun, Yankun Zhao, Yi Xiong, et al.. (2024). Facilitating integrative and personalized oncology omics analysis with UCSCXenaShiny. Communications Biology. 7(1). 1200–1200. 3 indexed citations
8.
Yang, Nong, Yongchang Zhang, Liang Zeng, et al.. (2023). The combination therapy of anlotinib and penpulimab for the treatment of small cell lung cancer after platinum-based chemotherapy: Results of a phase II exploratory study.. Journal of Clinical Oncology. 41(16_suppl). e20628–e20628.
9.
Yang, Nong, Juan Chen, Qian Chu, et al.. (2023). Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB–III non‐small cell lung cancer patients using radiomic features. Thoracic Cancer. 14(28). 2869–2876. 7 indexed citations
10.
Zeng, Liang, Yuling Zhou, Xiangyu Zhang, et al.. (2023). Copy number variations mediate major pathological response to induction chemo-immunotherapy in unresectable stage IIIA-IIIB lung cancer. Lung Cancer. 178. 134–142. 5 indexed citations
11.
Jiang, Wenjuan, Yuling Zhou, Liang Zeng, et al.. (2022). The efficacy and safety of albumin-bound paclitaxel plus carboplatin as neoadjuvant therapy for potentially resectable lung squamous cell carcinoma: a real-world retrospective cohort study. Translational Lung Cancer Research. 11(4). 647–655. 4 indexed citations
12.
Wang, Shixiang, Yi Xiong, Longfei Zhao, et al.. (2021). UCSCXenaShiny: an R/CRAN package for interactive analysis of UCSC Xena data. Bioinformatics. 38(2). 527–529. 97 indexed citations
13.
Zhou, Xiang, Yi Xiong, Ningyuan Chen, & Xuefeng Gao. (2021). Regime Switching Bandits. Neural Information Processing Systems. 34. 1 indexed citations
14.
Xiong, Yi, et al.. (2020). Identification of purity and prognosis‐related gene signature by network analysis and survival analysis in brain lower grade glioma. Journal of Cellular and Molecular Medicine. 24(19). 11607–11612. 20 indexed citations
15.
Zhang, Yongchang, Liang Zeng, Chunhua Zhou, et al.. (2020). Detection of Nonreciprocal/Reciprocal ALK Translocation as Poor Predictive Marker in Patients With First-Line Crizotinib-Treated ALK-Rearranged NSCLC. Journal of Thoracic Oncology. 15(6). 1027–1036. 42 indexed citations
16.
Zeng, Liang, Yizhi Li, Lili Xiao, et al.. (2018). Crizotinib presented with promising efficacy but for concomitant mutation in next-generation sequencing-identified ROS1-rearranged non-small-cell lung cancer. OncoTargets and Therapy. Volume 11. 6937–6945. 19 indexed citations
17.
Wang, Hui, Yi Xiong, Li Yan, et al.. (2014). Effect of Inhaled Magnesium Sulfate on Bronchial Hyperresponsiveness. The Indian Journal of Pediatrics. 82(4). 321–327. 6 indexed citations
18.
Fang, Zhengyu, Yi Xiong, Jiana Li, et al.. (2011). Detection of APC Gene Deletions in Colorectal Malignancies Using Quantitative PCR in a Chinese Population. Pathology & Oncology Research. 17(3). 657–661. 5 indexed citations
19.
Fang, Zhengyu, Wantong Yao, Yi Xiong, et al.. (2011). Attenuated expression of HRH4 in colorectal carcinomas: a potential influence on tumor growth and progression. BMC Cancer. 11(1). 195:1–11. 33 indexed citations
20.
Fang, Zhengyu, Wantong Yao, Yi Xiong, et al.. (2010). Functional elucidation and methylation‐mediated downregulation of ITGA5 gene in breast cancer cell line MDA‐MB‐468. Journal of Cellular Biochemistry. 110(5). 1130–1141. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hisafumi Yamada‐Okabe Breakdown of academic impact, for papers by Xiaoxing Wang Breakdown of academic impact, for papers by Hongtao Liu Breakdown of academic impact, for papers by Jae Yun Lim Breakdown of academic impact, for papers by Lin Tang Breakdown of academic impact, for papers by Xueyi Dong Breakdown of academic impact, for papers by Sang Seok Koh Breakdown of academic impact, for papers by Jean‐Philippe Theurillat
Rankless by CCL
2026